FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012304224> ?p ?o ?g. }

• W2012304224 abstract "To define the maximum tolerated dose (MTD) of irinotecan (CPT-11) given on days 1 and 8 with mitomycin C (MMC) given on day 1 in a monthly cycle, and to assess the toxicity and activity of this regimen in patients with previously treated colorectal carcinoma.Fifty-two patients, all pretreated with adjuvant 5-fluorouracil (20 patients) and/or one (35 patients) or two (8 patients) lines of chemotherapy, were entered in this study. Escalating doses of CPT-11 (starting from 150 mg/m2) were administered on days 1 and 8, with escalating doses of MMC (starting from 8 mg/m2) given on day 1, recycling every 28 days. At least 3 patients were treated at each dose level. Escalation proceeded unless 2 out of 3 or 4 out of 6 patients experienced a dose-limiting toxicity (DLT) after the first cycle.Twelve patients were entered in the phase I study, and 4 consecutive dose levels were tested. At the last dose level (CPT-11 200 mg/m2 plus MMC 10 mg/m2) 4 of 6 patients experienced a DLT (i.e., grade 4 neutropenia in 2 patients and grade 3 diarrhea in 2 patients). Therefore, this dose level was considered as the MTD. Forty patients were treated at the previous dose level (CPT-11, 175 mg/m2 plus MMC 10 mg/m2). One complete, 4 partial, 3 minor responses and 11 cases of stable disease were registered, giving a response rate of 12% [95% confidence interval (CI), 4-27%] and an overall control of tumor growth in 47% (95% CI, 31-64%) of patients. The median time to treatment failure was 6 months (range 1-19+). The median survival time was 14.5 months, and the 1-year and 2-year probability of survival were 56 and 43%. Neutropenia and diarrhea affected 62 and 58% of patients, grade 3 or 4 being registered in 26 and 23% of them, respectively. One episode of neutropenic fever was reported. Other acute toxicities were usually mild and manageable.CPT-11 175 mg/m2 on days 1 and 8 associated with MMC 10 mg/m2 on day 1, every 4 weeks, is a safe and moderately active regimen in heavily pretreated patients with advanced colorectal carcinoma. The role of MMC in this combination is doubtful, and further attempts with other new agents should be made to improve the outcome in these patients." @default.
• W2012304224 created "2016-06-24" @default.
• W2012304224 creator A5007383961 @default.
• W2012304224 creator A5021225962 @default.
• W2012304224 creator A5036443897 @default.
• W2012304224 creator A5038819793 @default.
• W2012304224 creator A5040974455 @default.
• W2012304224 creator A5056559714 @default.
• W2012304224 creator A5062603033 @default.
• W2012304224 creator A5066316788 @default.
• W2012304224 creator A5073695437 @default.
• W2012304224 creator A5088304855 @default.
• W2012304224 date "2001-01-01" @default.
• W2012304224 modified "2023-09-23" @default.
• W2012304224 title "Irinotecan and Mitomycin C in 5-Fluorouracil-Refractory Colorectal Cancer Patients" @default.
• W2012304224 cites W1480177090 @default.
• W2012304224 cites W1832060645 @default.
• W2012304224 cites W1918961940 @default.
• W2012304224 cites W1969861347 @default.
• W2012304224 cites W2006824814 @default.
• W2012304224 cites W2065961310 @default.
• W2012304224 cites W2089670274 @default.
• W2012304224 cites W2090082360 @default.
• W2012304224 cites W2096122707 @default.
• W2012304224 cites W2109558652 @default.
• W2012304224 cites W2165351839 @default.
• W2012304224 cites W2167805334 @default.
• W2012304224 cites W2261898534 @default.
• W2012304224 cites W2311628233 @default.
• W2012304224 cites W2410203379 @default.
• W2012304224 doi "https://doi.org/10.1159/000055309" @default.
• W2012304224 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11244327" @default.
• W2012304224 hasPublicationYear "2001" @default.
• W2012304224 type Work @default.
• W2012304224 sameAs 2012304224 @default.
• W2012304224 citedByCount "7" @default.
• W2012304224 countsByYear W20123042242020 @default.
• W2012304224 crossrefType "journal-article" @default.
• W2012304224 hasAuthorship W2012304224A5007383961 @default.
• W2012304224 hasAuthorship W2012304224A5021225962 @default.
• W2012304224 hasAuthorship W2012304224A5036443897 @default.
• W2012304224 hasAuthorship W2012304224A5038819793 @default.
• W2012304224 hasAuthorship W2012304224A5040974455 @default.
• W2012304224 hasAuthorship W2012304224A5056559714 @default.
• W2012304224 hasAuthorship W2012304224A5062603033 @default.
• W2012304224 hasAuthorship W2012304224A5066316788 @default.
• W2012304224 hasAuthorship W2012304224A5073695437 @default.
• W2012304224 hasAuthorship W2012304224A5088304855 @default.
• W2012304224 hasConcept C121608353 @default.
• W2012304224 hasConcept C126322002 @default.
• W2012304224 hasConcept C141071460 @default.
• W2012304224 hasConcept C142424586 @default.
• W2012304224 hasConcept C143998085 @default.
• W2012304224 hasConcept C2776694085 @default.
• W2012304224 hasConcept C2777334693 @default.
• W2012304224 hasConcept C2779338040 @default.
• W2012304224 hasConcept C2779682216 @default.
• W2012304224 hasConcept C2780259306 @default.
• W2012304224 hasConcept C2780456651 @default.
• W2012304224 hasConcept C29730261 @default.
• W2012304224 hasConcept C526805850 @default.
• W2012304224 hasConcept C55493867 @default.
• W2012304224 hasConcept C71924100 @default.
• W2012304224 hasConcept C86803240 @default.
• W2012304224 hasConcept C87355193 @default.
• W2012304224 hasConceptScore W2012304224C121608353 @default.
• W2012304224 hasConceptScore W2012304224C126322002 @default.
• W2012304224 hasConceptScore W2012304224C141071460 @default.
• W2012304224 hasConceptScore W2012304224C142424586 @default.
• W2012304224 hasConceptScore W2012304224C143998085 @default.
• W2012304224 hasConceptScore W2012304224C2776694085 @default.
• W2012304224 hasConceptScore W2012304224C2777334693 @default.
• W2012304224 hasConceptScore W2012304224C2779338040 @default.
• W2012304224 hasConceptScore W2012304224C2779682216 @default.
• W2012304224 hasConceptScore W2012304224C2780259306 @default.
• W2012304224 hasConceptScore W2012304224C2780456651 @default.
• W2012304224 hasConceptScore W2012304224C29730261 @default.
• W2012304224 hasConceptScore W2012304224C526805850 @default.
• W2012304224 hasConceptScore W2012304224C55493867 @default.
• W2012304224 hasConceptScore W2012304224C71924100 @default.
• W2012304224 hasConceptScore W2012304224C86803240 @default.
• W2012304224 hasConceptScore W2012304224C87355193 @default.
• W2012304224 hasLocation W20123042241 @default.
• W2012304224 hasLocation W20123042242 @default.
• W2012304224 hasOpenAccess W2012304224 @default.
• W2012304224 hasPrimaryLocation W20123042241 @default.
• W2012304224 hasRelatedWork W2114772012 @default.
• W2012304224 isParatext "false" @default.
• W2012304224 isRetracted "false" @default.
• W2012304224 magId "2012304224" @default.
• W2012304224 workType "article" @default.